The Drug Enforcement Administration (DEA) is seeking to negotiate a sole source procurement with Ntrepid, LLC for a fully integrated anonymization and evidence collection tool that includes non/misattribution capabilities. This procurement aims to enhance the DEA's operational capabilities in managing sensitive information while ensuring anonymity and integrity in evidence collection processes. The acquisition will be conducted under FAR Part 13 "Simplified Acquisition Procedures," with a firm-fixed-price purchase order anticipated. Interested vendors are invited to submit capability statements by September 18, 2024, at 10:00 AM EST, to Robert A. Jones Jr. at robert.a.jonesjr@dea.gov.